[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.90.95. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
January 1997

Ocular RosaceaCurrent Concepts and Therapy

Author Affiliations

Department of Dermatology School of Medicine University of Pennsylvania 415 Curie Blvd 226 Clinical Research B1 Philadelphia, PA 19104

Arch Dermatol. 1997;133(1):89-90. doi:10.1001/archderm.1997.03890370095014
Abstract

AMONG DERMATOLOGISTS, ocular rosacea may be designated as an orphan disease. It generally goes unrecognized, undiagnosed, undertreated, and underreported.

Many years ago, Duke-Elder,1 the doyen of academic ophthalmology, opined that ocular rosacea was a common disease but could offer no solid figures regarding its prevalence. Dermatologists and ophthalmologists record widely differing estimates. There are obvious reasons for these discrepancies. Dermatologists and ophthalmologists do not see the same patients; both suffer from monocular vision. Ophthalmologists focus on the eyes and dermatologists look at the skin. Systematic epidemiologic studies are totally lacking. Much disagreement would disappear if a dermatologist-ophthalmologist duo would combine to examine the same patients, recruited from their separate practices.

Then, too, the subjective symptoms of ocular rosacea, which are easily overlooked, are more common than the objective signs. They include nonspecific, rather common complaints, such as stinging, burning, tearing, photophobia, scratchiness, and feelings of foreign material in the

First Page Preview View Large
First page PDF preview
First page PDF preview
×